Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Aardvark Therapeutics, Inc. (AARD) vs. Competitors

142 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AARDAardvark Therapeutics, Inc.$1.00$21.89M-0.30-90.44%Moderate SellUnlock the AARD analyst price target with TipRanks PremiumAARDUnlock the AARD top-analyst price target with TipRanks Premium
CUECue Biopharma$4.50$37.62M-0.15-74.15%Moderate BuyUnlock the CUE analyst price target with TipRanks PremiumAARD vs CUEUnlock the CUE top-analyst price target with TipRanks Premium
EQEquillium$1.12$92.20M-6.3510.89%Strong BuyUnlock the EQ analyst price target with TipRanks PremiumAARD vs EQUnlock the EQ top-analyst price target with TipRanks Premium
ADCTADC Therapeutics$1.30$182.86M-2.49-67.66%HoldUnlock the ADCT analyst price target with TipRanks PremiumAARD vs ADCTUnlock the ADCT top-analyst price target with TipRanks Premium
NKTXNkarta$1.12$80.31M-0.65-37.43%Strong BuyUnlock the NKTX analyst price target with TipRanks PremiumAARD vs NKTXUnlock the NKTX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AARDAardvark Therapeutics, Inc.1.00-8.43-89.40%
CUECue Biopharma4.50-11.72-72.26%
EQEquillium1.120.1110.89%
ADCTADC Therapeutics1.30-2.69-67.42%
NKTXNkarta1.12-0.61-35.26%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts